申请人:HOFFMANN LA ROCHE
公开号:WO2014114573A1
公开(公告)日:2014-07-31
The present invention discloses compounds of Formula I: wherein the variables in Formula I are defined as described herein. Also disclosed are pharmaceutical compositions containing such compounds and methods for using the compounds of Formula I in the prevention or treatment of HCV infection.
本发明公开了式I化合物:式中,式I中的变量定义如所述。还公开了包含这种化合物的药物组合物以及使用式I化合物预防或治疗HCV感染的方法。